NCT07643831
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07643831
Title Expanded Access Program to Provide Giredestrant to Participants With ER+, HER2- Early or Locally Advanced/Metastatic Breast Cancer
Recruitment Available
Gender both
Phase Expanded access
Variant Requirements No
Sponsors Genentech, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
West Virginia University (WVU) - WVU Cancer Institute AVAILABLE Morgantown West Virginia 26506-1200 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field